הכנסה תפעולית לפני ניכוי פחת: orasure.com (OSUR)

Stable government contracts for infection diagnostics provide OraSure Technologies (OSUR) with a steady revenue stream, as reflected in the operational EBITDA, where the latest value is recorded as 0.00. To drive profit growth, the company is implementing robotic lines featuring AI recognition. Current margin stabilization is supported by long-term agreements with laboratories, which helps optimize expenses and break out of the sideways trend.

This indicator measures net cash flow from core commercial activities, demonstrating the business's actual ability to generate liquidity excluding debt load. For OraSure Technologies (OSUR), which has completed its asset restructuring, current operating cash flow confirms margin stabilization through long-term laboratory contracts, signaling the company's transition toward sustainable organic growth.